Trials / Completed
CompletedNCT02055378
the Effect of Low-Concentration Atropine Combined With Auricular Acupoint Stimulation in Myopia Control
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 73 (actual)
- Sponsor
- Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation · Academic / Other
- Sex
- All
- Age
- 6 Years – 12 Years
- Healthy volunteers
- Not accepted
Summary
To compare the effect of myopia control between patients treated with low-concentration atropine eye drops combined with auricular acupoint stimulation and those treated with atropine alone.
Detailed description
Myopia has been an increasing problem among school children, especially in Asian countries. High myopia is not only a refractive problem, but also a disease that can result in a number of sight-threatening complications such as macular degeneration, retinal detachment, glaucoma, and cataract. Atropine is a long-acting non-selective muscarinic antagonist that blocks accommodation by paralyzing ciliary muscles; it may affect remodeling of the sclera and suppress the elongation of axial length. Acupuncture and acupressure have been widely used in traditional Chinese medicine for thousands of years. Auricular acupoint stimulation by acupuncture or acupressure has been reported to improve visual acuity in myopic patients. Therefore, we want to compare the effect of myopia control between patients treated with low-concentration atropine eye drops combined with auricular acupoint stimulation and those who treated with atropine alone.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Atropine | topical 0.125% atropine eye drops |
| DEVICE | auricular acupoint stimulation | Five auricular acupoints (Shenmen, Xin, Yan, Mu 1 and Mu 2) Tapping stimulation was administered by using a 1-mm alloy ball (Magrain®; Sakamura, Kyoto, Japan) three times a day, each time for five minutes. |
Timeline
- Start date
- 2011-01-01
- Primary completion
- 2012-12-01
- Completion
- 2012-12-01
- First posted
- 2014-02-05
- Last updated
- 2014-02-05
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT02055378. Inclusion in this directory is not an endorsement.